Brainify.AI has reached a formal agreement with Reguard Health GmbH to become a distribution partner for the company’s BREEG™ next-generation EEG technology across Europe . The partnership will begin in Italy and expand into Italy, Germany, Switzerland, and Poland, establishing a major foothold for Brainify.AI’s neurotechnology platform in key European healthcare markets.
The agreement enables Reguard Health to deploy and commercialize Brainify.AI’s automated EEG-based brain health reports within hospital and clinical networks throughout the region. This includes core applications such as Alzheimer’s, Mild Cognitive Impairment, PTSD, and Healthy Brain Aging assessments, powered by Brainify.AI’s foundational EEG AI model.
The collaboration represents a significant step in scaling access to objective, AI-driven brain-health diagnostics across Europe, accelerating adoption of Brainify.AI’s BREEG technology while ensuring full compliance with EU data-governance and regulatory standards.